To improve the effectiveness of guidelines for the genetic referral of women newly diagnosed with ovarian cancer, clinicians need to obtain a thorough family history at diagnosis; arrange for reflex MMR IHC according to guidelines; offer BRCA or panel testing to all women with non-mucinous ovarian cancer prior to discharge and systematically follow up all women referred to genetics at the post-op visit.
Keyphrases
- newly diagnosed
- polycystic ovary syndrome
- end stage renal disease
- primary care
- palliative care
- healthcare
- genome wide
- breast cancer risk
- randomized controlled trial
- clinical practice
- chronic kidney disease
- systematic review
- pregnancy outcomes
- copy number
- prognostic factors
- low grade
- peritoneal dialysis
- mental health
- patient reported outcomes
- type diabetes
- pregnant women
- hepatitis c virus
- skeletal muscle
- men who have sex with men